215 related articles for article (PubMed ID: 35137191)
21. Yin-Yang 1 and HBx protein activate HBV transcription by mediating the spatial interaction of cccDNA minichromosome with cellular chromosome 19p13.11.
Shen C; Feng X; Mao T; Yang D; Zou J; Zao X; Deng Q; Chen X; Lu F
Emerg Microbes Infect; 2020 Dec; 9(1):2455-2464. PubMed ID: 33084547
[TBL] [Abstract][Full Text] [Related]
22. Host transcription factor Speckled 110 kDa (Sp110), a nuclear body protein, is hijacked by hepatitis B virus protein X for viral persistence.
Sengupta I; Das D; Singh SP; Chakravarty R; Das C
J Biol Chem; 2017 Dec; 292(50):20379-20393. PubMed ID: 29046350
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levels.
Ko C; Chakraborty A; Chou WM; Hasreiter J; Wettengel JM; Stadler D; Bester R; Asen T; Zhang K; Wisskirchen K; McKeating JA; Ryu WS; Protzer U
J Hepatol; 2018 Dec; 69(6):1231-1241. PubMed ID: 30142426
[TBL] [Abstract][Full Text] [Related]
24. T5 Exonuclease Hydrolysis of Hepatitis B Virus Replicative Intermediates Allows Reliable Quantification and Fast Drug Efficacy Testing of Covalently Closed Circular DNA by PCR.
Qu B; Ni Y; Lempp FA; Vondran FWR; Urban S
J Virol; 2018 Dec; 92(23):. PubMed ID: 30232183
[TBL] [Abstract][Full Text] [Related]
25. HBx represses WDR77 to enhance HBV replication by DDB1-mediated WDR77 degradation in the liver.
Yuan H; Zhao L; Yuan Y; Yun H; Zheng W; Geng Y; Yang G; Wang Y; Zhao M; Zhang X
Theranostics; 2021; 11(17):8362-8378. PubMed ID: 34373747
[No Abstract] [Full Text] [Related]
26. Hepatitis B virus X gene mutants emerge during antiviral therapy and increase cccDNA levels to compensate for replication suppression.
Lin CL; Chien RN; Chu YD; Liang KH; Huang YH; Ke PY; Lin KH; Lin YH; Yeh CT
Hepatol Int; 2020 Dec; 14(6):973-984. PubMed ID: 32770306
[TBL] [Abstract][Full Text] [Related]
27. The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro.
Salpini R; Surdo M; Cortese MF; Palumbo GA; Carioti L; Cappiello G; Spanò A; Trimoulet P; Fleury H; Vecchiet J; Pasquazzi C; Mirabelli C; Scutari R; Sacco A; Alkhatib M; Missale G; Francioso S; Sarmati L; Andreoni M; Angelico M; Ceccherini-Silberstein F; Levrero M; Perno CF; Belloni L; Svicher V
Clin Microbiol Infect; 2019 Jul; 25(7):906.e1-906.e7. PubMed ID: 30472417
[TBL] [Abstract][Full Text] [Related]
28. IL6 Inhibits HBV Transcription by Targeting the Epigenetic Control of the Nuclear cccDNA Minichromosome.
Palumbo GA; Scisciani C; Pediconi N; Lupacchini L; Alfalate D; Guerrieri F; Calvo L; Salerno D; Di Cocco S; Levrero M; Belloni L
PLoS One; 2015; 10(11):e0142599. PubMed ID: 26580974
[TBL] [Abstract][Full Text] [Related]
29. IFN-α2b inhibits the ethanol enriched-HBV cccDNA through blocking a positive feedback loop of HBx/MSL2/cccDNA/HBV/HBx in liver.
Liu Z; Wang J; Yuan H; Liu L; Bu Y; Zhao M; Yang G; Feng J; Liu Y; Li J; He Q; Zhang X
Biochem Biophys Res Commun; 2020 Jun; 527(1):76-82. PubMed ID: 32446394
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis B virus X protein mediated epigenetic alterations in the pathogenesis of hepatocellular carcinoma.
Yang L; Zou T; Chen Y; Zhao Y; Wu X; Li M; Du F; Chen Y; Xiao Z; Shen J
Hepatol Int; 2022 Aug; 16(4):741-754. PubMed ID: 35648301
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-33 mediates both immune-related and non-immune-related inhibitory effects against hepatitis B virus.
Gao Z; Shen Z; Wu J; Song Y; Liu N; Deng Q; Xie Y; Liu J
Antiviral Res; 2022 Oct; 206():105404. PubMed ID: 36049553
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis B protein HBx binds the DLEU2 lncRNA to sustain cccDNA and host cancer-related gene transcription.
Salerno D; Chiodo L; Alfano V; Floriot O; Cottone G; Paturel A; Pallocca M; Plissonnier ML; Jeddari S; Belloni L; Zeisel M; Levrero M; Guerrieri F
Gut; 2020 Nov; 69(11):2016-2024. PubMed ID: 32114505
[TBL] [Abstract][Full Text] [Related]
33. Replicative activity of hepatitis B virus is negatively associated with methylation of covalently closed circular DNA in advanced hepatitis B virus infection.
Kim JW; Lee SH; Park YS; Hwang JH; Jeong SH; Kim N; Lee DH
Intervirology; 2011; 54(6):316-25. PubMed ID: 21242658
[TBL] [Abstract][Full Text] [Related]
34. DNA Polymerase alpha is essential for intracellular amplification of hepatitis B virus covalently closed circular DNA.
Tang L; Sheraz M; McGrane M; Chang J; Guo JT
PLoS Pathog; 2019 Apr; 15(4):e1007742. PubMed ID: 31026293
[TBL] [Abstract][Full Text] [Related]
35. HBx relieves chromatin-mediated transcriptional repression of hepatitis B viral cccDNA involving SETDB1 histone methyltransferase.
Rivière L; Gerossier L; Ducroux A; Dion S; Deng Q; Michel ML; Buendia MA; Hantz O; Neuveut C
J Hepatol; 2015 Nov; 63(5):1093-102. PubMed ID: 26143443
[TBL] [Abstract][Full Text] [Related]
36. Cellular DNA Topoisomerases Are Required for the Synthesis of Hepatitis B Virus Covalently Closed Circular DNA.
Sheraz M; Cheng J; Tang L; Chang J; Guo JT
J Virol; 2019 Jun; 93(11):. PubMed ID: 30867306
[TBL] [Abstract][Full Text] [Related]
37. Retinoid X Receptor α-Dependent HBV Minichromosome Remodeling and Viral Replication.
Zhang Y; He S; Guo JJ; Peng H; Fan JH; Li QL
Ann Hepatol; 2017; 16(4):501-509. PubMed ID: 28611266
[TBL] [Abstract][Full Text] [Related]
38. Distinct distribution pattern of hepatitis B virus genotype C and D in liver tissue and serum of dual genotype infected liver cirrhosis and hepatocellular carcinoma patients.
Datta S; Roychoudhury S; Ghosh A; Dasgupta D; Ghosh A; Chakraborty BC; Ray S; Gupta S; Santra AK; Datta S; Das K; Dhali GK; Chowdhury A; Banerjee S
PLoS One; 2014; 9(7):e102573. PubMed ID: 25032957
[TBL] [Abstract][Full Text] [Related]
39. HBVcircle: A novel tool to investigate hepatitis B virus covalently closed circular DNA.
Yan Z; Zeng J; Yu Y; Xiang K; Hu H; Zhou X; Gu L; Wang L; Zhao J; Young JAT; Gao L
J Hepatol; 2017 Jun; 66(6):1149-1157. PubMed ID: 28213165
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of HBV Transcription From cccDNA With Nitazoxanide by Targeting the HBx-DDB1 Interaction.
Sekiba K; Otsuka M; Ohno M; Yamagami M; Kishikawa T; Suzuki T; Ishibashi R; Seimiya T; Tanaka E; Koike K
Cell Mol Gastroenterol Hepatol; 2019; 7(2):297-312. PubMed ID: 30704981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
